Geron
GERN
#6701
Rank
C$1.16 B
Marketcap
C$1.82
Share price
-1.52%
Change (1 day)
-0.04%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -C$48.98 Million

According to Geron's latest financial reports the company's current earnings are C$0.19 Billion. In 2025 the company made an earning of -C$71.12 Million, an increase over its 2024 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$48.98 Million-31.13%
2025 -C$71.12 Million-67.42%
2024 -C$0.22 Billion-11.23%
2023 -C$0.25 Billion30.22%
2022 -C$0.19 Billion20.15%
2021 -C$0.16 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$0.11 Billion130.68%
2018 -C$43.47 Million8.84%
2017 -C$39.94 Million-3.08%
2016 -C$41.2 Million-22080.6%
2015 C$0.18 M-100.38%
2014 -C$49.78 Million-7.14%
2013 -C$53.61 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$98.24 Million-2.51%
2008 -C$0.11 Billion14.65%
2007 -C$87.9 Million32.68%
2006 -C$66.25 Million25.59%
2005 -C$52.75 Million4.36%
2004 -C$50.55 Million19.73%
2003 -C$42.22 Million-15.46%
2002 -C$49.94 Million1.94%
2001 -C$48.99 Million33.59%
2000 -C$36.67 Million27.53%
1999 -C$28.75 Million63.13%
1998 -C$17.63 Million15.6%
1997 -C$15.25 Million-10.66%
1996 -C$17.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$15.00 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.48 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$96.85 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.21 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$20.87 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA